Shelly Davis
Nurse Practitioner · Tifton, GANPI 1386805885
Payments from drug & device makers
Across 240 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$830
- Novo Nordisk$461
- AstraZeneca$400
- Dexcom, Inc.$295
- Lilly USA, LLC$278
- Amgen$257
- plus $2K from 27 others
What the payments were for
- Food & beverage$4,288100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $830 |
| Novo Nordisk | 27 | $461 |
| AstraZeneca | 20 | $400 |
| Dexcom, Inc. | 17 | $295 |
| Lilly USA, LLC | 16 | $278 |
| Amgen(2 entities) | 15 | $257 |
| Pfizer | 12 | $237 |
| GSK | 11 | $225 |
| Astellas Pharma US Inc | 8 | $188 |
| Johnson & Johnson | 9 | $168 |
| Amarin Pharma, Inc. | 8 | $156 |
| Exact Sciences | 5 | $96 |
| Abbott | 5 | $88 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $63 |
| Bayer | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Sumitomo Pharma America, Inc. | 1 | $44 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $44 |
| Novartis | 2 | $44 |
| Corium, LLC | 2 | $41 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| IBSA Pharma Inc. | 2 | $31 |
| Merck | 2 | $29 |
| Medtronic | 1 | $25 |
| Boehringer Ingelheim | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $11 |
| Genentech USA, Inc. | 1 | $10 |
How this compares
$4,288 in reported general payments places this provider in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 63 | $90,885 |
| MounjaroTirzepatide | 41 | $59,812 |
| EliquisApixaban | 33 | $35,621 |
| XareltoRivaroxaban | 24 | $27,551 |
| OzempicSemaglutide | 23 | $22,205 |
| JanuviaSitagliptin Phosphate | 16 | $19,931 |
| LinzessLinaclotide | 16 | $19,711 |
| MyrbetriqMirabegron | 15 | $10,789 |
| JanumetSitagliptin Phos/Metformin Hcl | 11 | $8,412 |
| PremarinEstrogens, Conjugated | 16 | $4,648 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $4,484 |
| SynthroidLevothyroxine Sodium | 34 | $4,455 |
| Omeprazole | 147 | $2,484 |
| Levothyroxine Sodium | 247 | $2,472 |
| Rosuvastatin Calcium | 173 | $1,916 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $278 | $150,697104 claims |
| PfizerEliquis, Premarin | $237 | $40,26949 claims |
| MerckJanuvia, Janumet | $29 | $28,34327 claims |
| Johnson & JohnsonXarelto | $168 | $27,55124 claims |
| AbbVieLinzess, Synthroid | $830 | $24,16650 claims |
| Novo NordiskOzempic, Novolog | $461 | $23,22634 claims |
| Astellas Pharma US IncMyrbetriq | $188 | $10,78915 claims |
| AstraZenecaSymbicort | $400 | $4,48416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,328 nurse practitioner providers in Georgia.
Other nurse practitioner in Tifton
- Crystal LogsdonSavannah$566K
- Victor CzerkasijDalton$505K
- Kennon Mc CollumStockbridge$364K
- Pamela AllenRome$270K
- Tajuana BradleyJohns Creek$256K
- Janice McAlisterAtlanta$241K
- Jessica AdkinsSavannah$226K
- Laura ElledgeAtlanta$177K
- Afsha HussainiKennesaw$122K
- Elizabeth TyeAlbany$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.